75
We read the Article by Graham S Cooke and colleagues1 exploring strategies to optimise treatment for hepatitis C virus (HCV) infection. Their investigation into response-guided therapy (RGT) is particularly pertinent as clinicians seek to personalise treatment duration while maintaining high cure rates.
